Complexo Hospitalario Universitario de Santiago
Centro de atención
Hospital Vega Baja
Orihuela, EspañaPublicacións en colaboración con investigadores/as de Hospital Vega Baja (27)
2023
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
-
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
Patient Preference and Adherence, Vol. 17, pp. 839-849
-
Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
Clinical Cardiology, Vol. 46, Núm. 11, pp. 1390-1397
2022
-
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry
European Journal of Clinical Investigation, Vol. 52, Núm. 12
-
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Journal of Crohn's & colitis, Vol. 16, Núm. 7, pp. 1049-1058
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14
-
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry
Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529
-
Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29
-
Vericiguat in heart failure: from scientific evidence to clinical practice
Revista Clinica Espanola
2021
-
Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente
Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268
2020
-
Nutritional Risk and Mortality at One Year for Elderly Patients Hospitalized with Nonvalvular Atrial Fibrillation. NONAVASC Registry
Journal of Nutrition, Health and Aging
-
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)
Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388
2019
2018
-
Baseline functional status as the strongest predictor of in-hospital mortality in elderly patients with non-valvular atrial fibrillation: Results of the NONAVASC registry
European Journal of Internal Medicine, Vol. 47, pp. 69-74
-
Rivaroxaban: searching the integral vascular protection
Expert Review of Clinical Pharmacology, Vol. 11, Núm. 7, pp. 719-728
2017
-
Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)
Circulation, Vol. 135, Núm. 22, pp. 2133-2144
2016
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
-
Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergy
Immunotherapy, Vol. 8, Núm. 3, pp. 265-277